Skip to main content

Month: March 2026

PPHC Expands Strategic Advisory Platform with Appointment of TrailRunner Sports President

WASHINGTON, March 18, 2026 (GLOBE NEWSWIRE) — Public Policy Holding Company, Inc. (“PPHC” or “the Company”) (Nasdaq: PPHC), a leading global provider of strategic communications services, today announced that TrailRunner International (“TrailRunner”), one of the Company’s member firms, has named Alden Mitchell as President of TrailRunner Sports, its global sports advisory business. The appointment reflects PPHC’s continued investment in high-value growth areas across its platform. As the global sports industry grows in scale and institutional complexity, leagues, teams, ownership groups, universities, and brands increasingly require the same strategic communications and advisory capabilities that PPHC’s member firms deliver across corporate reputation, financial communications,...

Continue reading

SFL – Filing of Annual Report 2025 on form 20-F

SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) announces that its annual report on Form 20-F for the financial year ended December 31, 2025 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission (the “Commission”). The Annual Report may be accessed through SFL’s website, www.sflcorp.com, or directly in the link below. The Annual Report is also available on the website of the Commission at www.sec.gov. Shareholders may also receive a hard copy of the Annual Report, which includes the Company’s complete 2025 audited financial statements, free of charge, by submitting the contact form requesting the report at www.sflcorp.com. March 18, 2026 The Board of DirectorsSFL Corporation Ltd.Hamilton, Bermuda Questions can be directed to SFL Management AS: Investor...

Continue reading

WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (the “ISSUER”) (a public company incorporated with limited liability in Ireland) Resumption of Subscription Orders for WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged

18 March 2026 LEI: 2138003QW2ZAYZODBU23 WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (the “ISSUER”) (a public company incorporated with limited liability in Ireland)  Resumption of Subscription Orders for WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged We refer to a notice issued by the Issuer on 13 March 2026 (the “Notice”). Terms not defined herein shall have the meaning ascribed to them in the Notice or the base prospectus of the Issuer dated 25 September 2025. The Issuer wishes to announce that with effect from 8.00am (London time) on Wednesday, 18 March 2026, Subscription Orders from Authorised Participants in WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged (the “Affected Securities”) will be accepted. Please note that in accordance with Condition 17.1(B), the Issuer may be required...

Continue reading

nVent Highlights Portfolio Transformation and Growth Priorities at 2026 Investor Day

Outlines Rapidly Expanding Presence in Data Centers and Power Utilities Unveils Updated Three-Year Growth and Financial Targets LONDON, March 18, 2026 (GLOBE NEWSWIRE) — nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, today will host its 2026 Investor Day at 9:30 a.m. ET in New York City. At the event, nVent’s senior management will provide an in-depth review of the company’s portfolio transformation, growth strategy, and updated three-year financial targets. “We have reshaped nVent into a more focused, higher-growth electrical company that is well-positioned to capitalize on the growing trends of electrification, digitalization and sustainability. Our strategy is to continue driving accelerated growth with a focus on the infrastructure vertical, including data centers...

Continue reading

Parsons Honored as One of the World’s Most Ethical Companies for the 17th Consecutive Year

CHANTILLY, Va., March 18, 2026 (GLOBE NEWSWIRE) — Parsons Corporation announced today that it has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2026 World’s Most Ethical Companies. This marks the seventeenth consecutive year that the company has been honored with this recognition. In 2026, 138 honorees were recognized spanning 17 countries and 40 industries. Parsons is one of only four honorees in the Engineering Services category. “We are honored to be recognized as one of the World’s Most Ethical Companies for the 17th consecutive year,” said Carey Smith, chair, president, and chief executive officer for Parsons. “This recognition reflects the commitment of our employees to doing business with integrity, embedding ethical decision making into...

Continue reading

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

Portfolio receipts: • Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year 2025 • Total receipts increased 9% with royalties up 68% versus full year 2024 Business development: Added 22 assets to portfolio, including five programs in Phase 2 or Phase 3 development Stock buyback program: Repurchased and retired 648,048 shares for an aggregate of $16.0 million Company acquisitions: Completed seven acquisitions, accumulating $11.7 million of non-dilutive capital1, economic interests of approximately 25% in up to $1.1 billion of milestones and low to mid-single digit royalties from eight partnered programs Key 2026 pipeline events: • Phase 2b data from volixibat in PSC in Q2 and Phase 3 data from ersodetug in tumor HI in 2H • Potential for EMA decisions on OJEMDA™...

Continue reading

KBR Awarded Project Management Contract to Support Libya’s Downstream Expansion at Zallaf South Refinery

HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) announced today it has been awarded a contract by Zallaf Exploration, Production and Refining of Oil and Gas Company to provide project management and technical services for the South Refinery Project in Ubari, Southwest Libya. Under the terms of the contract, KBR will provide contract management, project management and supporting technical services throughout the EPC phases of the project. This work is expected to be executed over a 50-month period. The South Refinery Project aligns with KBR’s long-standing commitment to advancing vital oil and gas infrastructure in Libya. KBR has a proven track record of delivering successful projects in the country, including engineering services for major national programs such as the Great Man-Made River Project, widely recognized as...

Continue reading

T1 Energy Secures 50MW Grid Allocation for Nordic Data Center Asset

Norway’s power grid operator has assigned 50MW to T1 Energy, enabling advancement of existing industrial facility into a world-class data center AUSTIN, Texas and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) — T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) today announced that Norway’s national grid operator, Statnett, has assigned 50MW of grid power to T1 Energy’s existing 926,000-square-foot industrial building in Mo i Rana. T1 remains in the interconnection queue for 396MW of power and is grateful the grid operator recognized the importance of this 50MW accelerated power allocation to an existing industrial site. “T1 is building a solar supply chain to deliver scalable, reliable, and low-cost energy in the United States. Our legacy assets in the Nordics could be developed as world-class data centers utilizing the...

Continue reading

Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; Ovid advancing plans to initiate a Phase 2 trial in focal onset seizures and an open-label, proof-of-concept study Expanding OV329 development to complementary indications in tuberous sclerosis complex seizures and infantile spasms, supported by a $60.0 million private placement OV4071, a first-in-class, oral KCC2 direct activator, received Human Research Ethics Committee approval and acknowledgement of its Clinical Trial Notification from the Australian Therapeutic Goods Administration, triggering a 30-day exercise period for the Company’s outstanding Series A Warrants Company to host KCC2-focused R&D Day on April 14, 2026 $90.4 million in cash, cash equivalents and marketable securities...

Continue reading

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

STAFFORD, Texas, March 18, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided an update on the upcoming AACR Meeting 2026. Two abstracts and two posters were accepted for presentation. The titles and authors of the abstracts are as follows: Abstract Number: CT138 – Poster Section 52 on April 20, 2026, 2-5pm Abstract Title: Preliminary delayed-type-hypersensitivity immune response results from open-label arm of on-going Phase III study to evaluate the efficacy and safety of GLSI-100 (GP2 + GM-CSF) in breast cancer patients with residual disease or high-risk PCR after...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.